Which treatments for which patient?

Targeting fluoroquinolone prescribing in hospitals is effective, but many patients still get discharge prescriptions for them

Injectable sponge-like gel enhances the quantity and quality of T-cells

Measurement of AHNAK2 helps physicians make challenging diagnostic decisions

Predicting mortality is a key requirement for the technology to be more widely used

The unique structure of circRNA makes it an ideal candidate for biomarkers

Current tools used to predict prostate cancer progression are generally subjective, leading to differing interpretations

Informative studies comparing universal screening with the currently used risk-based strategy are lacking

In prenatal testing, genomics sometimes sees what genetic tests can’t